Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $126.2150 (-2.39%) ($126.2150 - $126.2150) on Mon. Jul. 12, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.44% (three month average) | RSI | 49 | Latest Price | $126.2150(-2.39%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND declines -1.1% a day on average for past five trading days. | Weekly Trend | LGND declines -1.5% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Value stock rally for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(58%) IWO(57%) IWM(55%) IWC(53%) IWN(50%) | Factors Impacting LGND price | LGND will decline at least -1.22% in a week (0% probabilities). VIXM(-26%) UUP(-17%) VXX(-16%) IGOV(-6%) UNG(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.22% (StdDev 2.44%) | Hourly BBV | -1.4 () | Intraday Trend | 0% | | | |
|
Resistance Level | $130.13 | 5 Day Moving Average | $128.3(-1.63%) | 10 Day Moving Average | $131.37(-3.92%) | 20 Day Moving Average | $130.13(-3.01%) | To recent high | -16.7% | To recent low | 11.7% | Market Cap | $2.028b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |